Autopsy report · NCT02494713

Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

“slow enrollment; resource re-allocation”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 1 year 11 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

The University of Texas Health Science Center, Houston

Sponsor type

University, hospital or other

Conditions

Prostate Cancer

Interventions

Degarelix; Doxorubicin; Ketoconazole; Docetaxel; Estramustine

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
  “Slow enrollment” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.